• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

二羟基-2-氨基四氢萘(DATs)对多巴胺及β型腺苷酸环化酶的影响。

The effect of dihydroxy-2-aminotetraline (DATs) on dopamine and beta type adenylate cyclases.

作者信息

Sheppard H, Burghardt C R, Long J P

出版信息

Res Commun Chem Pathol Pharmacol. 1978 Feb;19(2):213-24.

PMID:205926
Abstract

A number of DATS have been studied for agonist activity with dopamine (DA) and beta (beta) type adenylate cyclases and the most potent ones were found among the 6,7-DATs and the 5,6-DATs, respectively. None of the compounds tested possessed antagonist activity. The observed activities were not expected on the basis of structural analysis of model compounds such as apomorphine and 6,7-dihydroxy-1-benzyltetrahydroisoquinoline. A new view was constructed which suggests that the nitrogens of the DAT compounds were positioned better than those of the model compounds with regard to their binding sites.

摘要

已经对多种二烯丙基三硫(DATS)进行了与多巴胺(DA)和β型腺苷酸环化酶的激动剂活性研究,发现最有效的分别存在于6,7 - DATS和5,6 - DATS中。所测试的化合物均不具有拮抗剂活性。基于阿扑吗啡和6,7 - 二羟基 - 1 - 苄基四氢异喹啉等模型化合物的结构分析,无法预期观察到的活性。构建了一种新观点,表明二烯丙基三硫化合物的氮原子相对于其结合位点的定位比模型化合物的氮原子更好。

相似文献

1
The effect of dihydroxy-2-aminotetraline (DATs) on dopamine and beta type adenylate cyclases.二羟基-2-氨基四氢萘(DATs)对多巴胺及β型腺苷酸环化酶的影响。
Res Commun Chem Pathol Pharmacol. 1978 Feb;19(2):213-24.
2
Further characterization of structural requirements for agonists at the striatal dopamine D-1 receptor. Studies with a series of monohydroxyaminotetralins on dopamine-sensitive adenylate cyclase and a comparison with dopamine receptor binding.
Mol Pharmacol. 1982 Sep;22(2):281-9.
3
Further characterization of structural requirements for agonists at the striatal dopamine D2 receptor and a comparison with those at the striatal dopamine D1 receptor. Studies with a series of monohydroxyaminotetralins on acetylcholine release from rat striatum.纹状体多巴胺D2受体激动剂结构要求的进一步表征及其与纹状体多巴胺D1受体激动剂结构要求的比较。用一系列单羟基氨基四氢萘对大鼠纹状体乙酰胆碱释放的研究。
Mol Pharmacol. 1984 Nov;26(3):452-7.
4
Relative selectivity of 6,7-dihydroxy-2-dimethylaminotetralin, N-n-propyl-3-(3-hydroxyphenyl)piperidine, N-n-propylnorapomorphine and pergolide as agonists at striatal dopamine autoreceptors and postsynaptic dopamine receptors.6,7-二羟基-2-二甲基氨基四氢萘、N-正丙基-3-(3-羟基苯基)哌啶、N-正丙基去甲阿扑吗啡和培高利特作为纹状体多巴胺自身受体和突触后多巴胺受体激动剂的相对选择性。
J Pharmacol Exp Ther. 1985 Feb;232(2):519-25.
5
Dose related sequence of effects induced by the DA agonist 2-(N,N-dipropyl)-amino-5,6-dihydroxytetralin.多巴胺激动剂2-(N,N-二丙基)-氨基-5,6-二羟基四氢萘诱导的剂量相关效应序列
J Pharmacol. 1986 Jan-Mar;17(1):60-4.
6
Neurochemical and behavioral evidence that Ro 41-9067 is a selective presynaptic dopamine receptor agonist.神经化学及行为学证据表明Ro 41-9067是一种选择性突触前多巴胺受体激动剂。
J Pharmacol Exp Ther. 1993 Jul;266(1):97-105.
7
RDS-127 (2-di-n-propylamino-4,7-dimethoxyindane): central effects of a new dopamine receptor agonist.RDS - 127(2 - 二正丙基氨基 - 4,7 - 二甲氧基茚满):一种新型多巴胺受体激动剂的中枢效应
J Pharmacol Exp Ther. 1983 Jan;224(1):161-70.
8
Desensitization of adenylate cyclase and down regulation of beta adrenergic receptors after in vivo administration of beta agonist.体内给予β激动剂后腺苷酸环化酶的脱敏作用及β肾上腺素能受体的下调。
J Pharmacol Exp Ther. 1982 Nov;223(2):327-31.
9
Phenyliminoimidazolidines. Characterization of a class of potent agonists of octopamine-sensitive adenylate cyclase and their use in understanding the pharmacology of octopamine receptors.苯基亚氨基咪唑烷。一类章鱼胺敏感腺苷酸环化酶强效激动剂的表征及其在理解章鱼胺受体药理学中的应用。
Mol Pharmacol. 1985 Sep;28(3):254-68.
10
Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.介导大鼠纹状体腺苷酸环化酶活性抑制的多巴胺受体的特性分析。
Mol Pharmacol. 1985 Aug;28(2):138-45.